<p>We talk with Dr. Namit Chaudhary, a postdoctoral researcher in the Department of Immunology & Microbiology at The Scripps Research Institute, CA, who develops new technologies to generate a safe and effective single-shot lipid nanoparticle-based HIV vaccine. </p>

We talk with Dr. Namit Chaudhary, a postdoctoral researcher in the Department of Immunology & Microbiology at The Scripps Research Institute, CA, who develops new technologies to generate a safe and effective single-shot lipid nanoparticle-based HIV vaccine.

<p>We talk with Dr. Namit Chaudhary, a postdoctoral researcher in the Department of Immunology &amp; Microbiology at The Scripps Research Institute, CA, who develops new technologies to generate a safe and effective single-shot lipid nanoparticle-based HIV vaccine.&nbsp;</p>

Episode 23: Developing novel lipid nanoparticles to improve vaccine-induced immune responses

Hear from scientists working to develop new vaccines and understand immunity to microbial pathogens. 
Host: Larissa Thackray, Ph.D., Professor of Infectious Diseases

Science

Medicine

Health & Fitness

Education

Life Sciences

Hear from scientists working to develop new vaccines and understand immunity to microbial pathogens. Host: Larissa Thackray, Ph.D., Professor of Infectious Diseases

Share Episode 23: Developing novel lipid nanoparticles to improve vaccine-induced immune responses

Sign up to save your podcasts

Episode 23: Developing novel lipid nanoparticles to improve vaccine-induced immune responses

Episode 23: Developing novel lipid nanoparticles to improve vaccine-induced immune responses